Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia

被引：19
|
作者：
Rice, Lawrence
Hursting, Marcie J.
Baillie, G. Mark
McCollum, David A.
机构：
[1] Methodist Hosp, Weill Cornell Med Coll, Houston, TX 77030 USA
[2] Clin Sci Consulting, Austin, TX USA
[3] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 08期
关键词：
heparin-induced thrombocytopenia; obesity; argatroban; body mass index; thrombosis;
D O I：
10.1177/0091270007302951
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1028 / 1034
页数：7
相关论文
共 50 条
  • [21] Argatroban approved for heparin-induced thrombocytopenia
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (18) : 1650 - 1650
  • [22] Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia
    Lewis, BE
    Wallis, DE
    Berkowitz, SD
    Matthai, WH
    Fareed, J
    Walenga, JM
    Bartholomew, J
    Sham, R
    Lerner, RG
    Zeigler, ZR
    Rustagi, PK
    Jang, IK
    Rifkin, SD
    Moran, J
    Hursting, MJ
    Kelton, JG
    CIRCULATION, 2001, 103 (14) : 1838 - 1843
  • [23] Argatroban is a new option for patients with heparin-induced thrombocytopenia
    不详
    Drugs & Therapy Perspectives, 2001, 17 (19) : 1 - 4
  • [24] Argatroban use in patients with a history of heparin-induced thrombocytopenia who require acute anticoagulation.
    Matthai, WH
    Hursting, MJ
    Lewis, BE
    BLOOD, 2001, 98 (11) : 45A - 45A
  • [25] Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery
    Koster, Andreas
    Hentschel, Thomas
    Groman, Tom
    Kuppe, Hermann
    Hetzer, Roland
    Harder, Sebastian
    Fischer, Karl-Georg
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (05): : 1376 - 1377
  • [26] Successful coronary interventions performed with argatroban anticoagulation in patients with heparin-induced thrombocytopenia and thrombosis syndrome
    Lewis, BE
    Ferguson, JJ
    Grassman, ED
    Fareed, J
    Walenga, J
    Joffrion, JL
    Wrona, L
    Johnson, SA
    Schwarz, RP
    McKiernan, T
    JOURNAL OF INVASIVE CARDIOLOGY, 1996, 8 (09): : 410 - 417
  • [27] Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia
    Furukawa, K
    Ohteki, H
    ANNALS OF THORACIC SURGERY, 2004, 78 (06): : 2208 - 2208
  • [28] Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy
    LaMonte, MP
    Brown, PM
    Hursting, MJ
    CRITICAL CARE MEDICINE, 2004, 32 (04) : 976 - 980
  • [29] Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients
    Gray, Anthony
    Wallis, Diane E.
    Hursting, Marcie J.
    Katz, Eliezer
    Lewis, Bruce E.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (04) : 353 - 361
  • [30] Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia
    Duewell, Brittney E.
    Briski, Matthew J.
    Feih, Joel T.
    Rinka, Joseph R. G.
    Tawil, Justin N.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (04) : 529 - 534
12345